Literature DB >> 8150337

Prevalence of peptic ulcer in Helicobacter pylori positive blood donors.

D Vaira1, M Miglioli, P Mulè, J Holton, M Menegatti, M Vergura, G Biasco, R Conte, R P Logan, L Barbara.   

Abstract

This study aimed to determine the importance of raised antibodies to Helicobacter pylori in an asymptomatic population. A total of 128 asymptomatic blood donors who were seropositive for H pylori and consented to endoscopy were investigated. These subjects were from a population of 1010 blood donors screened for antibodies to H pylori. A questionnaire was completed to determine if any subjects had complained of symptoms, and they subsequently had endoscopy. Altogether 121 of 128 were positive for H pylori by histology and urease test and/or culture and all 121 had chronic active gastritis on histology. Twenty five of these subjects had peptic ulcer (20 duodenal, five gastric), a further 21 had erosive duodenitis, and two were found to have gastric cancer. H pylori associated peptic ulcer disease and duodenitis occur more frequently than previously recognised and this suggests that H pylori infection, even if asymptomatic, is of far greater clinical relevance than originally thought.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8150337      PMCID: PMC1374580          DOI: 10.1136/gut.35.3.309

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. A clinical follow-up study of 454 outpatients.

Authors:  P Sipponen; K Varis; O Fräki; U M Korri; K Seppälä; M Siurala
Journal:  Scand J Gastroenterol       Date:  1990-10       Impact factor: 2.423

2.  Increased incidence of Campylobacter pylori infection in gastroenterologists: further evidence to support person-to-person transmission of C. pylori.

Authors:  H M Mitchell; A Lee; J Carrick
Journal:  Scand J Gastroenterol       Date:  1989-05       Impact factor: 2.423

3.  Serum immunoglobulin G antibody levels for Campylobacter pylori diagnosis.

Authors:  D Vaira; J Holton
Journal:  Gastroenterology       Date:  1989-10       Impact factor: 22.682

4.  Towards a true prevalence of peptic ulcer: the Sørreisa gastrointestinal disorder study.

Authors:  B Bernersen; R Johnsen; B Straume; P G Burhol; T G Jenssen; P A Stakkevold
Journal:  Gut       Date:  1990-09       Impact factor: 23.059

5.  Seroepidemiology of Campylobacter pylori infection in various populations.

Authors:  F Mégraud; M P Brassens-Rabbé; F Denis; A Belbouri; D Q Hoa
Journal:  J Clin Microbiol       Date:  1989-08       Impact factor: 5.948

6.  Endoscopy in dyspeptic patients: is gastric mucosal biopsy useful?

Authors:  D Vaira; J Holton; J Osborn; L D'Anna; A Romanos; M Falzon; I McNeil
Journal:  Am J Gastroenterol       Date:  1990-06       Impact factor: 10.864

7.  Antibody to the gastric campylobacter-like organism ("Campylobacter pyloridis")--clinical correlations and distribution in the normal population.

Authors:  D M Jones; J Eldridge; A J Fox; P Sethi; P J Whorwell
Journal:  J Med Microbiol       Date:  1986-08       Impact factor: 2.472

8.  Seroepidemiology of Campylobacter pyloridis.

Authors:  A Morris; G Nicholson; G Lloyd; D Haines; A Rogers; D Taylor
Journal:  N Z Med J       Date:  1986-09-10

9.  The prevalence of Helicobacter pylori infection in the Peoples Republic of China.

Authors:  Y Y Li; P J Hu; G G Du; S L Hazell
Journal:  Am J Gastroenterol       Date:  1991-04       Impact factor: 10.864

10.  Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men.

Authors:  F Sitas; D Forman; J W Yarnell; M L Burr; P C Elwood; S Pedley; K J Marks
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

View more
  28 in total

1.  High prevalence of Helicobacter pylori infection in shepherds.

Authors:  M P Dore; M Bilotta; D Vaira; A Manca; G Massarelli; G Leandro; A Atzei; G Pisanu; D Y Graham; G Realdi
Journal:  Dig Dis Sci       Date:  1999-06       Impact factor: 3.199

2.  Incidence of Helicobacter pylori infection in a cohort of Italian military students.

Authors:  R Biselli; M Fortini; P M Matricardi; T Stroffolini; R D'Amelio
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

3.  Rabeprazole in treatment of acid peptic diseases: results of three placebo-controlled dose-response clinical trials in duodenal ulcer, gastric ulcer, and gastroesophageal reflux disease (GERD). The Rabeprazole Study Group.

Authors:  M L Cloud; N Enas; T J Humphries; S Bassion
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

4.  H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor?

Authors:  G Holtmann; J Gschossmann; M Holtmann; N J Talley
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 5.  Eradication of Helicobacter pylori should be pivotal in managing peptic ulceration. Eradication largely prevents relapse.

Authors:  C J Hawkey
Journal:  BMJ       Date:  1994-12-10

6.  Helicobacter pylori status, endoscopic findings, and serology in HIV-1-positive patients.

Authors:  D Vaira; M Miglioli; M Menegatti; J Holton; A Boschini; M Vergura; C Ricci; P Azzarone; P Mulè; L Barbara
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

7.  Clinical significance of Helicobacter pylori seropositivity and seronegativity in asymptomatic blood donors.

Authors:  M Menegatti; J Holton; N Figura; G Biasco; C Ricci; G Oderda; R Conte; M Miglioli; D Vaira
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 8.  Diagnostic methods for Helicobacter pylori detection and eradication.

Authors:  A F Goddard; R P H Logan
Journal:  Br J Clin Pharmacol       Date:  2003-09       Impact factor: 4.335

9.  High prevalence of Helicobacter pylori in liver cirrhosis: relationship with clinical and endoscopic features and the risk of peptic ulcer.

Authors:  S Siringo; D Vaira; M Menegatti; F Piscaglia; S Sofia; M Gaetani; M Miglioli; R Corinaldesi; L Bolondi
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

10.  Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects.

Authors:  D Vaira; N Vakil; M Rugge; L Gatta; C Ricci; M Menegatti; G Leandro; J Holton; V M Russo; M Miglioli
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.